Counselors in Otis, OR Accepting Medicare
10 Counselors found. Showing 1 - 10
 Jasmine Deelene Christiansen Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 3955 Salmon River Hwy, Otis, OR 97368 Phone: 541-614-4437 Fax: 888-977-2106 |
Mrs. Brandie Marie Randleman, CIT Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 3955 Salmon River Hwy, Otis, OR 97368 Phone: 541-614-4437 Fax: 888-977-2106 |
Alexis Graddy Counselor Medicare: Not Enrolled in Medicare Practice Location: 3955 Salmon River Hwy, Otis, OR 97368 Phone: 541-614-4437 Fax: 888-977-2106 |
Sarah Lynn Hostler Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 3955 Salmon River Hwy, Otis, OR 97368 Phone: 541-614-4437 Fax: 888-977-2106 |
Sheila Ruth Petersen, CADC-R Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 3955 Salmon River Hwy, Otis, OR 97368 Phone: 541-614-4437 |
Miss Christine Ann Massingale, CADC I Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 3955 Salmon River Hwy, Otis, OR 97368 Phone: 541-614-4437 Fax: 888-977-2106 |
 Jeb Zartman Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 3955 Salmon River Hwy, Otis, OR 97368 Phone: 541-614-4437 Fax: 888-977-2106 |
Zachary James Hoydic Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 3955 Salmon River Hwy, Otis, OR 97368 Phone: 541-614-4437 Fax: 888-977-2106 |
Miss Jessica Marie Homan, CIT Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 3555 Salmon River Hwy, Otis, OR 97368 Phone: 541-614-4437 Fax: 888-977-2106 |
Joshua D Bogart Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 727 N Deerlane Loop, Otis, OR 97368 Phone: 928-848-6430 |
News Archive
RTOG study likely treatment option for brain tumor patients like Sen. Kennedy
A Radiation Therapy Oncology Group (RTOG) study which seeks to establish whether high-doses of the chemotherapy drug temozolomide after radiotherapy can improve outcome for patients with newly diagnosed malignant glioma is a possible consideration for Sen. Edward Kennedy (D-Mass.) and other patients with this type of brain tumor.
Johns Hopkins devises new seizure detection software
Epilepsy affects 50 million people worldwide, but in a third of these cases, medication cannot keep seizures from occurring. One solution is to shoot a short pulse of electricity to the brain to stamp out the seizure just as it begins to erupt. But brain implants designed to do this have run into a stubborn problem: too many false alarms, triggering unneeded treatment. To solve this, Johns Hopkins biomedical engineers have devised new seizure detection software that, in early testing, significantly cuts the number of unneeded pulses of current that an epilepsy patient would receive.
Cancer patients not given enough information about survival benefits of palliative chemotherapy
Two thirds of cancer patients receive little or no information about the survival benefits of having palliative chemotherapy before making a decision about treatment, according to a study published today on bmj.com.
Techulon receives U.S. patent protection for Glycofect Discovery and Therapeutic Delivery Platform
Techulon, Inc. announced today that its Glycofect Discovery and Therapeutic Delivery Platform has been awarded United States patent protection. The patented invention provides a new class of non-viral transfection vectors based on synthetic carbohydrate containing polyamides that can be used for both in vivo and in vitro applications.
› Verified 4 days ago